SYED QUADRI: Open Payments
NPI 1992926307 · MICHIGAN CITY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,155 in 47 payments from 11 companies in 2025. Trend: 2023 $1,505 · 2024 $1,555 · 2025 $1,155
Food & beverage: $1,155
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $274 |
| Medtronic, Inc. | 3 | $202 |
| ABBVIE INC. | 7 | $157 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $144 |
| Collegium Pharmaceutical, Inc. | 7 | $121 |
| VERTEX PHARMACEUTICALS INCORPORATED | 5 | $96 |
| PFIZER INC. | 5 | $85 |
| TerSera Therapeutics LLC | 1 | $24 |
| Stryker Corporation | 1 | $22 |
| Lilly USA, LLC | 1 | $16 |
Products named: PROCLAIM, INCEPTIV, RELISTOR, JOURNAVX, QULIPTA, Belbuca, NURTEC ODT, UBRELVY.
Industry payments across IN — which companies pay providers there.
